FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Anu Laboratories IPO and MCX IPO.
Anu Laboratories IPO is a Mainline Book Built Issue IPO proposed to list at BSE while MCX IPO is a Mainline Book Built Issue proposed to list at BSE.
Anu Laboratories IPO | MCX IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE | BSE |
Lead Managers | Almondz Global Securities Limited | Citigroup Global Markets India Private Limited Edelweiss Financial Services Ltd Morgan Stanley India Company Pvt Ltd |
Registrar | Kfin Technologies Limited | Kfin Technologies Limited |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Anu Laboratories IPO is up to ₹80.22 Cr whereas the issue size of the MCX IPO is up to ₹663.31 Cr. The final issue price of Anu Laboratories IPO is ₹210.00 per share and of MCX IPO is ₹1,032.00 per share.
Anu Laboratories IPO | MCX IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹200.00 per share | ₹860.00 per share |
Issue Price (Upper) | ₹210.00 per share | ₹1,032.00 per share |
Issue Price (Final) | ₹210.00 per share | ₹1,032.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 30 shares | 6 shares |
Fresh Issue Size | ||
Fresh Issue Size (Amount) | ||
OFS Issue Size | ||
OFS Issue Size (Amount) | ||
Issue Size Total | 38,20,000 shares | 64,27,378 shares |
Issue Size Total (Amount) | up to ₹80.22 Cr | up to ₹663.31 Cr |
Anu Laboratories IPO opens on May 12, 2008, while MCX IPO opens on Feb 22, 2012. The closing date of Anu Laboratories IPO and MCX IPO is May 15, 2008, and Feb 24, 2012, respectively.
Anu Laboratories IPO | MCX IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | May 12, 2008 | Feb 22, 2012 |
Issue Close | May 15, 2008 | Feb 24, 2012 |
Basis Of Allotment (Tentative) | ||
Initiation of Refunds (Tentative) | ||
Credit of Share (Tentative) | ||
Listing date (Tentative) | ||
Anchor Lockin End date 1 | ||
Anchor Lockin End date 2 |
Anu Laboratories IPO P/E ratio is , as compared to MCX IPO P/E ratio of .
Anu Laboratories IPO | MCX IPO | |||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
Read MCX Annual Reports |
||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 31.18% | |||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 26% | |||||||||||||||||||||||||||||||||||||||||
P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||
Market Cap | ||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||
ROCE | ||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||
RoNW | 20.77%% |
In the Anu Laboratories IPO retail investors (RII) are offered while in MCX IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Anu Laboratories IPO and 21,62,083 shares in MCX IPO.
Anu Laboratories IPO | MCX IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | ||
QIB | 21,62,083 shares | |
NII | 9,26,607 shares | |
RII | 21,62,082 shares | |
Employee | 2,50,000 shares | |
Others | ||
Total | 55,00,772 shares |
Anu Laboratories IPO subscribed 8.43x in total, whereas MCX IPO subscribed 54.13x.
Anu Laboratories IPO | MCX IPO | |
---|---|---|
QIB (times) | 2.84x | 49.12x |
NII (times) | 26.97x | 150.35x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 9.64x | 24.14x |
Employee (times) | 1.00x | 0.18x |
Other (times) | ||
Total (times) | 8.43x | 54.13x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|